AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Feb 4, 2013
30016_dirs_2013-02-04_62ea7b4f-e12d-41cd-b53d-6261f026674f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-01-31
Reporting Person: NAQUI ALI (Corporate Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-31 | Common Stock | M | 11498 | $41.935 | Acquired | 23418 | Direct |
| 2013-01-31 | Common Stock | S | 8540 | $95.53 | Disposed | 14878 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-31 | Non-Qualified Stock Option (right to buy) | $41.935 | M | 8540 | Disposed | 2014-02-13 | Common Stock (8540) | Direct |
| 2013-01-31 | Incentive Stock Option (right to buy) | $41.935 | M | 2958 | Disposed | 2014-02-13 | Common Stock (2958) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock becomes exercisable as to 2,300 shares on 02/14/2008, 02/14/2009 and 02/14/2010 and the remaining 1,640 shares on 02/14/2011.
F2: Grant of options to buy shares of common stock becomes exercisable as to 660 shares on 02/14/2011 and the remaining 2,298 shares on 02/14/2012.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13